Microbot Medical stock target raised to $9 by H.C. Wainwright
H.C. Wainwright's valuation of Microbot Medical (NASDAQ:MBOT) stands at an estimated market value of $255 million, or $9 per share, which underpins the revised price target. The current market ...
Bitcoin Weekly Forecast: BTC holdings of large investors surges as Trump takes the Oval Office
According to the report, large investors have accumulated Bitcoin again ahead of President Trump’s inauguration. As shown in ...
Canaccord maintains Buy rating on MP Materials stock, $26 target
Canaccord Genuity maintained its optimistic stance on MP Materials (NYSE: MP), reiterating a Buy rating with a set price target of $26.00. The firm's analysis highlighted MP Materials' leading role in ...